by Age | Cachexia (weight loss) | Complementary and Alternative | Fatigue | 
First line | by Grade | by Phase | By Stage
Quality of Life | by Stage | Refractory

or select from menu:

Click here to request a trial search

 by Age

Click here for meaning of Phase I, II, III studies.

Return to top

Investigational therapies for lymphomas:

	Children all phases - Phase I | Phase II | Phase III
	Elderly - all phases - Phase I | Phase II | Phase III

for Cachexia 
(cancer-associated weight loss)

Return to top

Investigational therapies for :

Cachexia

Complementary &
Alternative Medicine (CAM)

The objective of responsible CAM practices are generally to improve quality of life, general health or performance - or to mitigate the side effects of therapy. 

It is unethical to prescribe CAM practices as therapy for lymphoma or other cancers outside of a clinical trial.

Return to top

Investigational therapies for lymphomas:

	CAM studies for lymphoma
	Quality of Life (QOL)

Fatigue studies

Return to top

First-line for
previously untreated

"First line" means that participants must have had no prior treatment (or significant treatment), not that the therapy is superior.

Return to top

Investigational therapies for previously untreated lymphomas:

Note: This criteria (untreated) is challenging to filter for by query command. Please confirm that the protocols listed are truly for untreated lymphoma by reading the eligibility sections.

Trials by subtype and treatment status PDF / Web

Treatment-specific first-line studies:

	Chemotherapy, but not doxorubicin (component of CHOP)
	Excluding chemotherapy or transplants
	Antibodies - excluding chemotherapy or transplants
	Vaccines

by Grade of Lymphoma

Grade refers to how aggressive or indolent (slow growing)  the lymphoma is. Grade I is generally most  indolent, and Grade III is most aggressive.

Return to top

Investigational therapies for lymphomas by rate of growth:

	Grade I | Grade II  | Grade III
	Indolent lymphomas
	Untreated indolent lymphoma
	Indolent recurrent lymphomas
	Transformed lymphoma (indolent changed to aggressive)
	Aggressive lymphomas
	Aggressive recurrent lymphoma

by Phase of Study

Click here for meaning
of Phase I, II, III studies.

Return to top

Investigational therapies for lymphomas or CLL:

	All studies and phases Phase I trials | Phase II | Phase III  | Phase IV
	Expanded Access (See for background on compassionate use)

Quality of Life studies

Return to top

Investigational therapies for:

Quality of Life (QOL)

by Stage 

Stage refers to how widespread the disease is.

Return to top

Investigational therapies for lymphomas:

	All therapies for all stages - Stage I | Stage II | Stage III | Stage IV
	Radiotherapy -  Stage I | Stage II | Stage III | Stage IV

studies for Refractory
Lymphomas

Refractory refers to disease that is resistant to standard treatments.

It is a term without precise definition, however ... in that refractory to therapy A does not mean the lymphoma is not sensitive to therapy B, for example.

Return to top

Studies for refractory (treatment resistant) lymphomas: 

	See also Pipeline for single agents
	Trials by subtype and treatment status PDF / Web
	All Lymphoma     NHL-indolent | NHL - aggressive | Hodgkins | T-cell

Treatment-specific studies for refractory lymphomas: 

Immunotherapy

Stem Cell Transplants (SCT):

	Autologous (stem cells from self)  All lymphomas | CLL/SLL | NHL | Hodgkin's | T-cell
	Allogeneic (stem cells from donor)  All lymphomas | NHL | Hodgkin's | T-cell
	Mini-transplants (stem cells from donor)   All lymphomas | NHL | Hodgkin's | T-cell  (non-myeloablative transplant)
	Refractory AND NOT SCT  All lymphomas | NHL | Hodgkin's | T-cell